Evidence map›Paper›PMID 27655329›Full record

ArticleBMC psychiatry2016

An explorative study of school performance and antipsychotic medication.

J van der Schans, S Vardar, R Çiçek, H J Bos, P J Hoekstra, T W de Vries, E Hak

Open access · goldAbstract read
In one paragraph

Article in BMC psychiatry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. In the Real-World, Kids Use Medications and Devices.Drugs - real world outcomes · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

J van der SchansDepartment of Pharmacy, PharmacoTherapy, -Epidemiology & -Economics, University of Groningen, Antionius Deuginslaan 1, Groningen, 9713 AV, The Netherlands. J.van.der.schans@rug.nl.
S VardarDepartment of Pharmacy, PharmacoTherapy, -Epidemiology & -Economics, University of Groningen, Antionius Deuginslaan 1, Groningen, 9713 AV, The Netherlands.
R ÇiçekDepartment of Pharmacy, PharmacoTherapy, -Epidemiology & -Economics, University of Groningen, Antionius Deuginslaan 1, Groningen, 9713 AV, The Netherlands.
H J BosDepartment of Pharmacy, PharmacoTherapy, -Epidemiology & -Economics, University of Groningen, Antionius Deuginslaan 1, Groningen, 9713 AV, The Netherlands.
P J HoekstraDepartment of Psychiatry, University of Groningen, University Medical Center Groningen, Hanzeplein 1, Groningen, 9713 GZ, The Netherlands.
T W de VriesDepartment of Pediatrics, Medical Center Leeuwarden, Henri Dunantweg 2, Leeuwarden, 8934 AD, The Netherlands.
E HakDepartment of Pharmacy, PharmacoTherapy, -Epidemiology & -Economics, University of Groningen, Antionius Deuginslaan 1, Groningen, 9713 AV, The Netherlands.
University of Groningen · NLMedisch Centrum Leeuwarden · NLUniversity Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAntipsychotic therapy can reduce severe symptoms of psychiatric disorders, however, data on school performance among children on such treatment are lacking. The objective was to explore school performance among children using antipsychotic drugs at the end of primary education.

methodsA cross-sectional study was conducted using the University Groningen pharmacy database linked to academic achievement scores at the end of primary school (Dutch Cito-test) obtained from Statistics Netherlands. Mean Cito-test scores and standard deviations were obtained for children on antipsychotic therapy and reference children, and statistically compared using analyses of covariance. In addition, differences in subgroups as boys versus girls, ethnicity, household income, and late starters (start date within 12 months of the Cito-test) versus early starters (start date > 12 months before the Cito-test) were tested.

resultsIn all, data from 7994 children could be linked to Cito-test scores. At the time of the Cito-test, 45 (0.6 %) were on treatment with antipsychotics. Children using antipsychotics scored on average 3.6 points lower than the reference peer group (534.5 ± 9.5). Scores were different across gender and levels of household income (p < 0.05). Scores of early starters were significantly higher than starters within 12 months (533.7 ± 1.7 vs. 524.1 ± 2.6).

conclusionThis first exploration showed that children on antipsychotic treatment have lower school performance compared to the reference peer group at the end of primary school. This was most noticeable for girls, but early starters were less affected than later starters. Due to the observational cross-sectional nature of this study, no causality can be inferred, but the results indicate that school performance should be closely monitored and causes of underperformance despite treatment warrants more research.

Indexed as

Academic performanceAntipsychotic treatmentChildrenPharmacoepidemiology

Identifiers

PMID27655329
PMCPMC5031249
OpenAlexW2521597529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.